Oregon biotech could get defense spending funding…


AVI Biopharma could get some defense spending dollars to research some potential treatments for “terror-oriented” diseases. I have been following this company for quite a while and it is interesting to watch the attempts to get a product to market.

They have struggled for years to get recognition of the technology they hold, and to find someone to help them bring a drug to a Phase III trial. It is my understanding that a Phase III trial is very expensive.

The press releases about past trials are usually impressive to the biotech naive (like myself). I wonder why they haven’t been helped by any big pharma company…

Be Sociable, Share!
  1. No comments yet.
(will not be published)